journal article·2025-03-12

Multivalent RGD Peptide-Mediated Nanochimera for Lysosomal Degradation of PDL1 Protein

Yanfei Song, Linjie Cui, Zhilin Liu, Zhaohui Tang, Xuesi Chen

Nano Letters· Volume 25· Issue 10
Publisher page

Abstract

The development of immune checkpoint inhibitors, especially PDL1 antibodies, has revolutionized cancer therapy, but the posttherapy recycling of PDL1 proteins poses a significant challenge by inducing resistance and reducing treatment efficacy. To address this, we introduce an integrin-driven, lysosome-targeted nanochimera, composed of poly(glutamic acid), RGD peptides, and PDL1 antibodies, is designed to engage the target PDL1 protein, with the α v β 3 integrin binding to the multivalent RGD peptides to direct the complex through the endocytosomal pathway to the lysosome, ensuring PDL1 degradation and blocking its recycling. Our in vitro and in vivo experiments demonstrate that these nanochimeras potently activate T-cell antitumor immunity by downregulating PDL1 expression within tumor cells and tissues, significantly enhancing the efficacy of PDL1 antibodies. A key discovery of our study is the pivotal role of multivalent RGD peptides in facilitating target protein degradation, providing valuable insights for the development of more efficacious and sophisticated immunotherapies.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Polymer Science and Technology, Key Laboratory of Polymer Ecomaterials

Changchun Institute of Applied Chemistry, Chinese Academy of Sciences

School of Applied Chemistry and Engineering

University of Science and Technology of China

Funding

Natural Science Foundation of Jilin Province · National Key Research and Development Program of China · National Natural Science Foundation of China

References (37)

Show source-provided references
1. 10.1158/2159-8290.CD-18-036710.1158/2159-8290.CD-18-0367 ↗
2. 10.1056/NEJMoa120069410.1056/NEJMoa1200694 ↗
3. 10.1056/NEJMe170118210.1056/NEJMe1701182 ↗
4. 10.1016/S0140-6736(16)00561-410.1016/S0140-6736(16)00561-4 ↗
5. 10.1038/nature2364310.1038/nature23643 ↗
6. 10.1172/JCI16045610.1172/JCI160456 ↗
7. 10.1038/s41419-020-03140-210.1038/s41419-020-03140-2 ↗
8. 10.1038/s41586-020-2545-910.1038/s41586-020-2545-9 ↗
9. 10.1038/s41589-021-00770-110.1038/s41589-021-00770-1 ↗
10. 10.1038/s41589-021-00851-110.1038/s41589-021-00851-1 ↗
11. 10.1021/acscentsci.1c0014610.1021/acscentsci.1c00146 ↗
12. 10.1002/advs.20230892410.1002/advs.202308924 ↗
13. 10.1021/jacs.0c1000810.1021/jacs.0c10008 ↗
14. 10.1021/jacs.1c0852110.1021/jacs.1c08521 ↗
15. 10.1002/anie.20210217010.1002/anie.202102170 ↗
16. 10.1021/jacs.3c0389910.1021/jacs.3c03899 ↗
17. 10.1016/j.molcel.2019.09.00910.1016/j.molcel.2019.09.009 ↗
18. 10.1038/s41467-022-28520-410.1038/s41467-022-28520-4 ↗
19. 10.1021/jacs.3c0768710.1021/jacs.3c07687 ↗
20. 10.1002/advs.20230536410.1002/advs.202305364 ↗
21. 10.1002/anie.20230069410.1002/anie.202300694 ↗
22. 10.1021/jacs.3c0510910.1021/jacs.3c05109 ↗
23. 10.1021/jacs.4c0246310.1021/jacs.4c02463 ↗
24. 10.1021/jacs.2c0836710.1021/jacs.2c08367 ↗
25. 10.1016/j.biomaterials.2013.12.01810.1016/j.biomaterials.2013.12.018 ↗
26. 10.1016/j.biomaterials.2013.10.07210.1016/j.biomaterials.2013.10.072 ↗
27. 10.1002/adma.20210937610.1002/adma.202109376 ↗
28. 10.1021/acs.jmedchem.1c0139610.1021/acs.jmedchem.1c01396 ↗
29. 10.1021/acsbiomaterials.7b0085610.1021/acsbiomaterials.7b00856 ↗
30. 10.1021/acsomega.2c0268310.1021/acsomega.2c02683 ↗
31. 10.1021/jm050947h10.1021/jm050947h ↗
32. 10.1016/j.biomaterials.2014.04.03110.1016/j.biomaterials.2014.04.031 ↗
33. 10.1002/chem.20200111510.1002/chem.202001115 ↗
34. 10.1002/adma.20200209410.1002/adma.202002094 ↗
35. 10.1002/adma.20230037710.1002/adma.202300377 ↗
36. 10.1021/nn301148e10.1021/nn301148e ↗
37. 10.1002/adma.20220612110.1002/adma.202206121 ↗